ITEMS IN AFP WITH KEYWORD:

Constipation

Oct 1, 2017 Issue
Laxatives for the Management of Childhood Constipation [Cochrane for Clinicians]

Polyethylene glycol (PEG) is superior to placebo (mean difference [MD] = 2.61 more stools per week; 95% confidence interval [CI], 1.15 to 4.08), lactulose (MD = 0.70; 95% CI, 0.10 to 1.31), and milk of magnesia (MD = 0.69; 95% CI, 0.48 to 0.89) at increasing the number of bowel movements per week at two to 12 weeks.


Sep 15, 2015 Issue
Management of Constipation in Older Adults [Article]

Find out which bulking agents, osmotic and stimulant laxatives, and stool softeners are most effective. Also, review key behavioral interventions that can help prevent constipation in this population.


Jul 15, 2014 Issue
Evaluation and Treatment of Constipation in Children and Adolescents [Article]

Learn the differential diagnosis of constipation in children and effective treatments, such as parental education, behavior interventions, diet changes, and medications.


May 1, 2014 Issue
20-Year History of Diarrhea with Intermittent Constipation [Photo Quiz]

Photo Quiz presents readers with a clinical challenge based on a photograph or other image.


Dec 1, 2011 Issue
Management of Constipation in Patients Receiving Palliative Care [Cochrane for Clinicians]

There is insufficient evidence to recommend one laxative over another for the treatment of constipation in patients receiving palliative care. Methylnaltrexone can increase the frequency of bowel movements at four hours (odds ratio = 7.0; 95% confidence interval, 3.8 to 12.6) and at 24 hours (odds r...


Aug 1, 2011 Issue
Diagnostic Approach to Chronic Constipation in Adults [Article]

Constipation is traditionally defined as three or fewer bowel movements per week. Risk factors for constipation include female sex, older age, inactivity, low caloric intake, low-fiber diet, low income, low educational level, and taking a large number of medications. Chronic constipation is classifi...


Apr 15, 2011 Issue
Constipation in Adults [Clinical Evidence Handbook]

What are the effects of nondrug interventions, fiber supplements, and paraffin in adults with idiopathic chronic constipation? What are the effects of stimulant and osmotic laxatives? What are the effects of prostaglandin derivatives and 5-hydroxytryptamine 4 receptor agonists in persons with idiopathic chronic constipation?


Sep 15, 2010 Issue
Methylnaltrexone (Relistor) for Opioid-Induced Constipation [STEPS]

Methylnaltrexone can temporarily relieve opioid-induced constipation in patients with advanced illness who have not responded to laxative treatment. However, it must be given by injection, is expensive, and has been studied only for short-term use.


Oct 15, 2006 Issue
Lubiprostone (Amitiza) for Chronic Idiopathic Constipation [STEPS]

Although bulk or osmotic laxatives are less expensive first options for treating patients with chronic idiopathic constipation, lubiprostone is an alternative for those who do not tolerate or respond to these agents, or in patients older than 65 years in whom tegaserod use is not recommended.


Oct 15, 2006 Issue
Hirschsprung's Disease: Diagnosis and Management [Article]

Hirschsprung's disease (congenital megacolon) is caused by the failed migration of colonic ganglion cells during gestation. Varying lengths of the distal colon are unable to relax, causing functional colonic obstruction. Hirschsprung's disease most commonly involves the rectosigmoid region of the co...


Pages: 1 2 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now